SB 6202
In CommitteeSenate
Medicaid/fertility services
Providing coverage for standard fertility preservation services for medicaid enrollees.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires Washington’s Medicaid program to cover fertility preservation services—such as egg or sperm freezing—for enrollees facing medical treatments (like chemotherapy or radiation) that may cause infertility. It ensures these services are covered without extra restrictions or cost-sharing, recognizing them as medically necessary care.
- Starting January 1, 2027, Medicaid must cover all standard fertility preservation services for enrollees at risk of infertility due to medical treatment.
- Fertility medications must be covered without extra restrictions (e.g., higher copays or prior authorization requirements) compared to other prescription drugs.
- No benefit caps, waiting periods, or other limitations can be applied to fertility preservation services beyond those applied to other covered medical services.
- ‘Standard fertility preservation services’ are defined as medically necessary procedures consistent with guidelines from the American Society of Clinical Oncology or American Society for Reproductive Medicine for patients facing treatments (e.g., chemotherapy, radiation) that may impair fertility.
- The bill explicitly states that fertility preservation is part of the standard of care and medically necessary to address infertility risk from life-saving treatments.
Who is affected
- Medicaid enrollees — Medicaid-enrolled individuals diagnosed with cancer or other conditions requiring treatments (like chemotherapy, radiation, or stem cell transplants) that may cause infertility; they gain access to covered fertility preservation services without extra cost-sharing or restrictions.
- Young cancer patients and others at risk of infertility — Youth and young adults facing life-threatening illnesses who are at risk of losing fertility due to treatment; they gain time-sensitive access to medically necessary fertility preservation before starting treatment.
- Medicaid managed care organizations and healthcare providers — Health plans and providers that serve Medicaid patients must now cover fertility preservation services without imposing extra restrictions or cost-sharing beyond what applies to other covered services.
- State health agencies — State government agencies responsible for administering Medicaid (including the Department of Health and Health Care Authority) must implement new coverage requirements and track associated costs.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (4)
Prohibits Medicaid programs and managed care organizations from imposing extra restrictions—such as higher copays, prior authorization, or benefit caps—on fertility preservation services, ensuring equitable access consistent with other covered medical services.
HealthcarePeopleRef: Sec. 2(2)(a)-(b)Defines 'standard fertility preservation services' by referencing established clinical guidelines (ASCO and ASRM), grounding coverage in evidence-based medicine and reducing arbitrary administrative barriers to care.
HealthcarePeopleRef: Sec. 2(3)Recognizes fertility preservation as medically necessary and part of the standard of care, reinforcing patient autonomy and reproductive decision-making rights for vulnerable populations facing life-threatening illness.
Rights & LibertiesPeopleRef: Sec. 1(1)(c)-(d)Supports long-term psychosocial well-being and quality of life for young cancer survivors by reducing the psychological burden of losing future reproductive options during crisis decision-making.
Public SafetyPeopleRef: Sec. 2(1)
Potential Concerns (1)
Expands Medicaid coverage to include fertility preservation services for enrollees at risk of infertility due to life-saving medical treatments, improving access to time-sensitive, medically necessary care for low-income patients who otherwise could not afford it.
HealthcarePeopleRef: Sec. 2(1)
Who Is Most Affected
Medicaid enrollees—especially young adults and adolescents diagnosed with cancer—gain direct, time-sensitive access to fertility preservation without financial or administrative barriers. This is especially impactful for those without private insurance or whose plans exclude such services.
Young cancer patients and others facing infertility risk benefit from preserved reproductive autonomy and reduced psychological distress. However, the benefit is contingent on timely diagnosis and referral before treatment begins.
Medicaid managed care organizations and providers must integrate fertility preservation into care pathways, but face no new financial burden—costs are covered under existing Medicaid reimbursement structures. Administrative burden may increase slightly due to new documentation requirements.
State agencies (HCA, DOH) will incur modest implementation costs (e.g., provider education, billing updates, utilization tracking), but these are offset by improved health outcomes and reduced long-term behavioral health costs.
Fertility clinics and reproductive endocrinologists may see increased demand from Medicaid patients, but reimbursement rates remain unchanged. Some may benefit from expanded patient volume, though administrative overhead may rise.